




















![]()
Mirum Pharmaceuticals, Inc. (MIRM) Q1 2026 Earnings Call May 6, 2026 4:30 PM EDT
Company Participants
Andrew McKibben - Senior Vice President, Strategic Finance & Investor Relations
Christopher Peetz - CEO & Director
Peter Radovich - COO & President
Eric Bjerkholt - Chief Financial Officer
Joanne M. Quan - Chief Medical Officer
Conference Call Participants
Yesha Patel - Evercore ISI Institutional Equities, Research Division
Joshua Schimmer - Cantor Fitzgerald & Co., Research Division
Jonathan Wolleben - Citizens JMP Securities, LLC, Research Division
Rohit Bhasin - Morgan Stanley, Research Division
James Condulis - Stifel, Nicolaus & Company, Incorporated, Research Division
Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division
Lisa Walter - RBC Capital Markets, Research Division
Jessica Fye - JPMorgan Chase & Co, Research Division
Ryan Mcelroy - Leerink Partners LLC, Research Division
Ryan Deschner - Raymond James & Associates, Inc., Research Division
Joseph Thome - TD Cowen, Research Division
Charles Wallace - H.C. Wainwright & Co, LLC, Research Division
Presentation
Operator
Good afternoon, and welcome to Mirum Pharmaceuticals First Quarter 2026 Earnings Conference Call. My name is Tracy, and I will be your operator today. [Operator Instructions]
I would now like to hand the call -- the conference over to Andrew McKibben, SVP of Strategic Finance and Investor Relations. Please go ahead.
Andrew McKibben
Senior Vice President, Strategic Finance & Investor Relations
Thank you, Tracy, and good afternoon, everyone. I'd like to welcome you to Mirum Pharmaceuticals First Quarter 2026 Earnings Conference Call. For our prepared remarks, I'm joined today by our Chief Executive Officer, Chris Peetz; our President and Chief Operating Officer, Peter Radovich; and Eric Bjerkholt, our Chief Financial Officer. Our Chief Medical Officer, Joanne Quan, will be joining us for Q&A.
Earlier this afternoon, Mirum issued a press release reporting our first quarter 2026 financial results. Copies of the press release and our SEC filings are available on the
此内容由惯性聚合(RSS阅读器)自动聚合整理,仅供阅读参考。 原文来自 — 版权归原作者所有。